Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)

Martine Extermann, Matti Aapro, Roberto Bernabei, Harvey Jay Cohen, Jean Pierre Droz, Stuart Lichtman, Vincent Mor, Silvio Monfardini, Lazzaro Repetto, Liv Sørbye, Eva Topinkova

Research output: Contribution to journalArticle

694 Citations (Scopus)

Abstract

Background: As more and more cancers occur in elderly people, oncologists are increasingly confronted with the necessity of integrating geriatric parameters in the treatment of their patients. Methods: The International Society of Geriatric Oncology (SIOG) created a task force to review the evidence on the use of a comprehensive geriatric assessment (CGA) in cancer patients. A systematic review of the evidence was conducted. Results: Several biological and clinical correlates of aging have been identified. Their relative weight and clinical usefulness is still poorly defined. There is strong evidence that a CGA detects many problems missed by a regular assessment in general geriatric and in cancer patients. There is also strong evidence that a CGA improves function and reduces hospitalization in the elderly. There is heterogeneous evidence that it improves survival and that it is cost-effective. There is corroborative evidence from a few studies conducted in cancer patients. Screening tools exist and were successfully used in settings such as the emergency room, but globally were poorly tested. The article contains recommendations for the use of CGA in research and clinical care for older cancer patients. Conclusions: A CGA, with or without screening, and with follow-up, should be used in older cancer patients, in order to detect unaddressed problems, improve their functional status, and possibly their survival. The task force cannot recommend any specific tool or approach above others at this point and general geriatric experience should be used.

Original languageEnglish
Pages (from-to)241-252
Number of pages12
JournalCritical Reviews in Oncology/Hematology
Volume55
Issue number3
DOIs
Publication statusPublished - Sep 2005

Fingerprint

Geriatric Assessment
Advisory Committees
Geriatrics
Neoplasms
Survival
Hospital Emergency Service
Hospitalization
Weights and Measures
Costs and Cost Analysis
Research

Keywords

  • Aged >70
  • Cancer
  • Comprehensive geriatric assessment
  • Consensus
  • Screening
  • Systematic review

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Use of comprehensive geriatric assessment in older cancer patients : Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). / Extermann, Martine; Aapro, Matti; Bernabei, Roberto; Cohen, Harvey Jay; Droz, Jean Pierre; Lichtman, Stuart; Mor, Vincent; Monfardini, Silvio; Repetto, Lazzaro; Sørbye, Liv; Topinkova, Eva.

In: Critical Reviews in Oncology/Hematology, Vol. 55, No. 3, 09.2005, p. 241-252.

Research output: Contribution to journalArticle

Extermann, M, Aapro, M, Bernabei, R, Cohen, HJ, Droz, JP, Lichtman, S, Mor, V, Monfardini, S, Repetto, L, Sørbye, L & Topinkova, E 2005, 'Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)', Critical Reviews in Oncology/Hematology, vol. 55, no. 3, pp. 241-252. https://doi.org/10.1016/j.critrevonc.2005.06.003
Extermann, Martine ; Aapro, Matti ; Bernabei, Roberto ; Cohen, Harvey Jay ; Droz, Jean Pierre ; Lichtman, Stuart ; Mor, Vincent ; Monfardini, Silvio ; Repetto, Lazzaro ; Sørbye, Liv ; Topinkova, Eva. / Use of comprehensive geriatric assessment in older cancer patients : Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). In: Critical Reviews in Oncology/Hematology. 2005 ; Vol. 55, No. 3. pp. 241-252.
@article{c1b2d73dfcf14b3db8a5417fb461d025,
title = "Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)",
abstract = "Background: As more and more cancers occur in elderly people, oncologists are increasingly confronted with the necessity of integrating geriatric parameters in the treatment of their patients. Methods: The International Society of Geriatric Oncology (SIOG) created a task force to review the evidence on the use of a comprehensive geriatric assessment (CGA) in cancer patients. A systematic review of the evidence was conducted. Results: Several biological and clinical correlates of aging have been identified. Their relative weight and clinical usefulness is still poorly defined. There is strong evidence that a CGA detects many problems missed by a regular assessment in general geriatric and in cancer patients. There is also strong evidence that a CGA improves function and reduces hospitalization in the elderly. There is heterogeneous evidence that it improves survival and that it is cost-effective. There is corroborative evidence from a few studies conducted in cancer patients. Screening tools exist and were successfully used in settings such as the emergency room, but globally were poorly tested. The article contains recommendations for the use of CGA in research and clinical care for older cancer patients. Conclusions: A CGA, with or without screening, and with follow-up, should be used in older cancer patients, in order to detect unaddressed problems, improve their functional status, and possibly their survival. The task force cannot recommend any specific tool or approach above others at this point and general geriatric experience should be used.",
keywords = "Aged >70, Cancer, Comprehensive geriatric assessment, Consensus, Screening, Systematic review",
author = "Martine Extermann and Matti Aapro and Roberto Bernabei and Cohen, {Harvey Jay} and Droz, {Jean Pierre} and Stuart Lichtman and Vincent Mor and Silvio Monfardini and Lazzaro Repetto and Liv S{\o}rbye and Eva Topinkova",
year = "2005",
month = "9",
doi = "10.1016/j.critrevonc.2005.06.003",
language = "English",
volume = "55",
pages = "241--252",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Use of comprehensive geriatric assessment in older cancer patients

T2 - Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)

AU - Extermann, Martine

AU - Aapro, Matti

AU - Bernabei, Roberto

AU - Cohen, Harvey Jay

AU - Droz, Jean Pierre

AU - Lichtman, Stuart

AU - Mor, Vincent

AU - Monfardini, Silvio

AU - Repetto, Lazzaro

AU - Sørbye, Liv

AU - Topinkova, Eva

PY - 2005/9

Y1 - 2005/9

N2 - Background: As more and more cancers occur in elderly people, oncologists are increasingly confronted with the necessity of integrating geriatric parameters in the treatment of their patients. Methods: The International Society of Geriatric Oncology (SIOG) created a task force to review the evidence on the use of a comprehensive geriatric assessment (CGA) in cancer patients. A systematic review of the evidence was conducted. Results: Several biological and clinical correlates of aging have been identified. Their relative weight and clinical usefulness is still poorly defined. There is strong evidence that a CGA detects many problems missed by a regular assessment in general geriatric and in cancer patients. There is also strong evidence that a CGA improves function and reduces hospitalization in the elderly. There is heterogeneous evidence that it improves survival and that it is cost-effective. There is corroborative evidence from a few studies conducted in cancer patients. Screening tools exist and were successfully used in settings such as the emergency room, but globally were poorly tested. The article contains recommendations for the use of CGA in research and clinical care for older cancer patients. Conclusions: A CGA, with or without screening, and with follow-up, should be used in older cancer patients, in order to detect unaddressed problems, improve their functional status, and possibly their survival. The task force cannot recommend any specific tool or approach above others at this point and general geriatric experience should be used.

AB - Background: As more and more cancers occur in elderly people, oncologists are increasingly confronted with the necessity of integrating geriatric parameters in the treatment of their patients. Methods: The International Society of Geriatric Oncology (SIOG) created a task force to review the evidence on the use of a comprehensive geriatric assessment (CGA) in cancer patients. A systematic review of the evidence was conducted. Results: Several biological and clinical correlates of aging have been identified. Their relative weight and clinical usefulness is still poorly defined. There is strong evidence that a CGA detects many problems missed by a regular assessment in general geriatric and in cancer patients. There is also strong evidence that a CGA improves function and reduces hospitalization in the elderly. There is heterogeneous evidence that it improves survival and that it is cost-effective. There is corroborative evidence from a few studies conducted in cancer patients. Screening tools exist and were successfully used in settings such as the emergency room, but globally were poorly tested. The article contains recommendations for the use of CGA in research and clinical care for older cancer patients. Conclusions: A CGA, with or without screening, and with follow-up, should be used in older cancer patients, in order to detect unaddressed problems, improve their functional status, and possibly their survival. The task force cannot recommend any specific tool or approach above others at this point and general geriatric experience should be used.

KW - Aged >70

KW - Cancer

KW - Comprehensive geriatric assessment

KW - Consensus

KW - Screening

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=24044454968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24044454968&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2005.06.003

DO - 10.1016/j.critrevonc.2005.06.003

M3 - Article

C2 - 16084735

AN - SCOPUS:24044454968

VL - 55

SP - 241

EP - 252

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 3

ER -